These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6455538)

  • 1. A seroepidemiological study of measles infection in normal and handicapped persons in Lagos, Nigeria.
    Ogunmekan DA; Bracken P; Marshall WC
    J Trop Med Hyg; 1981 Aug; 84(4):175-8. PubMed ID: 6455538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles HI-antibody levels in Lagos children, Nigeria: a follow-up study to resurgence of measles in Lagos metropolis.
    Oyefolu AO; Omilabu SA
    West Afr J Med; 2001; 20(3):238-42. PubMed ID: 11922159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination levels associated with lack of measles transmission among preschool-aged populations in the United States, 1989-1991.
    Hutchins SS; Baughman AL; Orr M; Haley C; Hadler S
    J Infect Dis; 2004 May; 189 Suppl 1():S108-15. PubMed ID: 15106099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles infection following immunization: a report on forty-nine cases in Lagos, NIgeria.
    Williams GA
    Afr J Med Sci; 1971 Apr; 2(2):159-63. PubMed ID: 5111615
    [No Abstract]   [Full Text] [Related]  

  • 6. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.
    Ueda S; Okuno Y; Sakamoto Y
    Biken J; 1970 Sep; 13(3):175-8. PubMed ID: 4249672
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
    Ikić DM
    Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles outbreak in the Republic of the Marshall Islands, 2003.
    Hyde TB; Dayan GH; Langidrik JR; Nandy R; Edwards R; Briand K; Konelios M; Marin M; Nguyen HQ; Khalifah AP; O'leary MJ; Williams NJ; Bellini WJ; Bi D; Brown CJ; Seward JF; Papania MJ
    Int J Epidemiol; 2006 Apr; 35(2):299-306. PubMed ID: 16299123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
    Harry TO; Ogunmekan DA
    Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002.
    Yaméogo KR; Perry RT; Yaméogo A; Kambiré C; Kondé MK; Nshimirimana D; Kezaala R; Hersh BS; Cairns KL; Strebel P
    Int J Epidemiol; 2005 Jun; 34(3):556-64. PubMed ID: 15659463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EPI sentinel surveillance for Kwara, 1982-1987.
    Babaniyi O
    West Afr J Med; 1993; 12(4):218-22. PubMed ID: 8199064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trend of measles morbidity in Thailand.
    Ariyasriwatana C
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S707-18. PubMed ID: 14700171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measles in Poland in 2004].
    Czarkowski MP; Kondej B; Paweł S
    Przegl Epidemiol; 2006; 60(3):383-8. PubMed ID: 17249157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule.
    Domínguez A; Torner N; Barrabeig I; Rovira A; Rius C; Cayla J; Plasencia E; Minguell S; Sala MR; Martínez A; Costa J; Mosquera M; Cabezas C;
    Clin Infect Dis; 2008 Nov; 47(9):1143-9. PubMed ID: 18823269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
    Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
    Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
    Cutts FT; Monteiro O; Tabard P; Cliff J
    Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.